142 related articles for article (PubMed ID: 6245205)
1. Effects of delta 9-tetrahydrocannabinol and cannabidiol on sodium-dependent high affinity choline uptake in the rat hippocampus.
Lindamood C; Colasanti BK
J Pharmacol Exp Ther; 1980 May; 213(2):216-21. PubMed ID: 6245205
[TBL] [Abstract][Full Text] [Related]
2. Effects of cannabinoids on levels of acetylcholine and choline and on turnover rate of acetylcholine in various regions of the mouse brain.
Tripathi HL; Vocci FJ; Brase DA; Dewey WL
Alcohol Drug Res; 1987; 7(5-6):525-32. PubMed ID: 3620017
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological interaction of the effects of delta 9-trans-tetrahydrocannabinol and cannabidiol on serum corticosterone levels in rats.
Zuardi AW; Teixeira NA; Karniol IC
Arch Int Pharmacodyn Ther; 1984 May; 269(1):12-9. PubMed ID: 6087750
[TBL] [Abstract][Full Text] [Related]
4. Effects of the cannabinoids on physical properties of brain membranes and phospholipid vesicles: fluorescence studies.
Hillard CJ; Harris RA; Bloom AS
J Pharmacol Exp Ther; 1985 Mar; 232(3):579-88. PubMed ID: 2983062
[TBL] [Abstract][Full Text] [Related]
5. Effects of delta 9-tetrahydrocannabinol on prostaglandin formation in brain.
Reichman M; Nen W; Hokin LE
Mol Pharmacol; 1987 Nov; 32(5):686-90. PubMed ID: 2824983
[TBL] [Abstract][Full Text] [Related]
6. The effects of delta9-tetrahydrocannabinol and cannabidiol on the metabolism of gonadal steroids in the rat.
List A; Nazar B; Nyquist S; Harclerode J
Drug Metab Dispos; 1977; 5(3):268-72. PubMed ID: 17525
[TBL] [Abstract][Full Text] [Related]
7. Delta 9-tetrahydrocannabinol increases arachidonic acid levels in guinea pig cerebral cortex slices.
Reichman M; Nen W; Hokin LE
Mol Pharmacol; 1988 Dec; 34(6):823-8. PubMed ID: 2849049
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoids: influence on neurotransmitter uptake in rat brain synaptosomes.
Banerjee SP; Snyder SH; Mechoulam R
J Pharmacol Exp Ther; 1975 Jul; 194(1):74-81. PubMed ID: 168349
[TBL] [Abstract][Full Text] [Related]
9. Differential effect of cannabinol and cannabidiol on THC-induced responses during abstinence in morphine-dependent rats.
Hine B; Torrelio M; Gershon S
Res Commun Chem Pathol Pharmacol; 1975 Sep; 12(1):185-8. PubMed ID: 1237925
[TBL] [Abstract][Full Text] [Related]
10. Effects of chronic delta-9-tetrahydrocannabinol (THC) administration on neurotransmitter concentrations and receptor binding in the rat brain.
Ali SF; Newport GD; Scallet AC; Gee KW; Paule MG; Brown RM; Slikker W
Neurotoxicology; 1989; 10(3):491-500. PubMed ID: 2576303
[TBL] [Abstract][Full Text] [Related]
11. Effects of systemic and intraventricular administration of cannabinoids on schedule-controlled responding in the squirrel monkey.
Carney JM; Balster RL; Martin BR; Harris LS
J Pharmacol Exp Ther; 1979 Sep; 210(3):399-404. PubMed ID: 113528
[TBL] [Abstract][Full Text] [Related]
12. Cannabidiol--antiepileptic drug comparisons and interactions in experimentally induced seizures in rats.
Consroe P; Wolkin A
J Pharmacol Exp Ther; 1977 Apr; 201(1):26-32. PubMed ID: 850145
[TBL] [Abstract][Full Text] [Related]
13. Effect of cannabinoids on the turnover rate of acetylcholine in rat hippocampus, striatum and cortex.
Revuelta AV; Moroni F; Cheney DL; Costa E
Naunyn Schmiedebergs Arch Pharmacol; 1978 Sep; 304(2):107-10. PubMed ID: 703853
[TBL] [Abstract][Full Text] [Related]
14. Effects of delta-9-tetrahydrocannabinol on sensory evoked hippocampal activity in the rat: principal components analysis and sequential dependency.
Hampson RE; Foster TC; Deadwyler SA
J Pharmacol Exp Ther; 1989 Dec; 251(3):870-7. PubMed ID: 2557421
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterization of cannabinoids in the elevated plus maze.
Onaivi ES; Green MR; Martin BR
J Pharmacol Exp Ther; 1990 Jun; 253(3):1002-9. PubMed ID: 2162942
[TBL] [Abstract][Full Text] [Related]
16. In vitro alteration of the subcellular distribution of 3H-reserpine in the rat forebrain by delta 9-tetrahydrocannabinol.
Johnson KM; Dewey WL; Ho BT
Res Commun Chem Pathol Pharmacol; 1976 Dec; 15(4):655-71. PubMed ID: 1005913
[TBL] [Abstract][Full Text] [Related]
17. delta 9-Tetrahydrocannabinol differentially affects sensory-evoked potentials in the rat dentate gyrus.
Campbell KA; Foster TC; Hampson RE; Deadwyler SA
J Pharmacol Exp Ther; 1986 Dec; 239(3):936-40. PubMed ID: 3025423
[TBL] [Abstract][Full Text] [Related]
18. Psychoactive cannabinoids reduce gastrointestinal propulsion and motility in rodents.
Shook JE; Burks TF
J Pharmacol Exp Ther; 1989 May; 249(2):444-9. PubMed ID: 2542532
[TBL] [Abstract][Full Text] [Related]
19. Comparative diuretic activity of delta9-tetrahydrocannabinol, cannabidiol, cannabinol and hydrochlorothiazide in the rat.
Sofia RD; Knobloch LC; Harakal JJ; Erikson DJ
Arch Int Pharmacodyn Ther; 1977 Jan; 225(1):77-87. PubMed ID: 849066
[TBL] [Abstract][Full Text] [Related]
20. Effects of delta 1-tetrahydrocannabinol on cyclic AMP in cultured human diploid fibroblasts.
Kelly LA; Butcher RW
J Cyclic Nucleotide Res; 1979; 5(4):303-13. PubMed ID: 91629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
